News – Page 2 – SciCross

17 Mar

SciCross receives funding from VINNOVA

SciCross has received a grant from the Swedish innovation agency VINNOVA for development of innovative methods to reduce drug immunogenicity.

10 Mar

ABIRISK results presented at SSI meeting

SciCross collaborators within the ABIRISK project will present results at the Scandinavian Society of Immunology meeting in Iceland later this year. The title is “Development of Antidrug Antibodies in Multiple Sclerosis Cohorts in Europe – Overview of Interferon Beta and Natalizumab Cases Tested for ADA in Different Countries”

01 May

SciCross joins ABIRISK IMI project

SciCross has joined the IMI ABIRISK consortia, focused on understanding the mechanisms and consequences of drug immunogenicity of biopharmaceuticals. The project runs until November 2017 and has a total budget of approximately 33M euro.